Showing results (61-70 of 79) with videos related to
Sort By:
Pageof 8
The Journal of Rheumatology|February 17, 2019
OMERACT 2018 Modified Patient-reported Outcome Domain Core Set in the Life Impact Area for Adult Idiopathic Inflammatory MyopathiesMalin Regardt, Christopher A Mecoli, Jin Kyun Park, et al.The Journal of Rheumatology|September 17, 2018
Perceptions of Patients, Caregivers, and Healthcare Providers of Idiopathic Inflammatory Myopathies: An International OMERACT StudyChristopher A Mecoli, Jin Kyun Park, Helene Alexanderson, et al.Annals of the Rheumatic Diseases|October 11, 2017
Abatacept in the treatment of adult dermatomyositis and polymyositis: a randomised, phase IIb treatment delayed-start trialAnna Tjärnlund, Quan Tang, Cecilia Wick, et al.Plos One|August 23, 2017
Effect of endurance exercise on microRNAs in myositis skeletal muscle-A randomized controlled studyJessica F Boehler, Marshall W Hogarth, Matthew D Barberio, et al.Journal of Autoimmunity|January 10, 2026
Sera from patients with dermatomyositis and antisynthetase syndrome mediate muscle weakness, impair mitochondrial respiration and induce local cytokine production in muscle tissueCecilia Leijding, Stefano Gastaldello, Tomas Schiffer, et al.Seminars in Arthritis and Rheumatism|September 9, 2020
Assessing the content validity of patient-reported outcome measures in adult myositis: A report from the OMERACT myositis working groupTina Esfandiary, Jin Kyun Park, Helene Alexanderson, et al.Seminars in Arthritis and Rheumatism|June 8, 2024
The impact of pain on daily activities in patients with idiopathic inflammatory myopathies: Report from the OMERACT myositis working groupDidem Saygin, Helene Alexanderson, Dana DiRenzo, et al.Seminars in Arthritis and Rheumatism|August 19, 2024
Construct validity of PROMIS pain interference, fatigue, and physical function as patient-reported outcomes in adults with idiopathic inflammatory myopathies: An international study from the OMERACT myositis working groupEllen Romich, Didem Saygin, Dana DiRenzo, et al.Seminars in Arthritis and Rheumatism|January 19, 2024
Patient global assessment and inflammatory markers in patients with idiopathic inflammatory myopathies - A longitudinal studyKarin Lodin, Fabricio Espinosa-Ortega, Maryam Dastmalchi, et al.Seminars in Arthritis and Rheumatism|November 21, 2022
Reliability and validity of PROMIS physical function, pain interference, and fatigue as patient reported outcome measures in adult idiopathic inflammatory myopathies: International study from the OMERACT myositis working groupDana DiRenzo, Didem Saygin, Ingrid de Groot, et al.Pageof 8